deltatrials
Terminated NA NCT00470353

Cholecalciferol and Calcium Carbonate in Treating Patients With Colon Cancer That Has Been Removed by Surgery

A Pilot Study of Low and High Dose Vitamin Cholecalciferol (D3) With Pharmacokinetic and Pharmacodynamic Correlates in Patients With Resected Colon Cancer

Sponsor: Roswell Park Cancer Institute

Conditions Colorectal Cancer
Interventions biopsy calcium carbonate cholecalciferol immunohistochemistry staining method laboratory biomarker analysis pharmacological study
Updated 6 times since 2017 Last updated: Aug 2, 2023 Started: Sep 30, 2006 Primary completion: Jul 31, 2008 Completion: Sep 30, 2009

A NA clinical study on Colorectal Cancer, this trial is terminated or withdrawn. The trial is conducted by Roswell Park Cancer Institute and has accumulated 6 data snapshots since 2006. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated NA

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated NA

  3. Sep 2023 — Jul 2024 [monthly]

    Terminated NA

  4. Jan 2021 — Sep 2023 [monthly]

    Terminated NA

  5. Jun 2018 — Jan 2021 [monthly]

    Terminated NA

▶ Show 1 earlier version

  1. Jan 2017 — Jun 2018 [monthly]

    Terminated NA

    First recorded

Sep 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Roswell Park Cancer Institute
Data source: Roswell Park Cancer Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Buffalo, United States